I believe in Generic also. I try to get that when available.
But my question was AFTER the research develpment costs have been paid back the problem I have is the cost of the drug is not prorated down to a decent profit margin which would still make everyone money but the consumer could afford much better.
Our insurance costs would go down. The people without insurance could afford to get well.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.